The effect of antimicrobials on verocytotoxin bacteriophage transduction under bovine rumen fluid and broth conditions by Nyambe, Sepa et al.
Research Article • DOI: 10.1515/ijafr-2017-0008  IJAFR • 56(1) • 2017 • 77-84
Irish Journal of Agricultural and Food Research
77
The effect of antimicrobials on verocytotoxin 
bacteriophage transduction under bovine rumen fluid 
and broth conditions
1Food Safety Department, Teagasc Food Research Centre, Ashtown, Dublin 15, Ireland
2School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland
S. Nyambe1,2, C. Burgess1, P. Whyte2, D. Bolton1†
Abstract
The verocytotoxin genes in verocytotoxigenic Escherichia coli (VTEC) are carried by bacteriophages, incorporated into the 
bacterial genome (prophage). Antibiotics may promote phage replication and release to infect other cells (transduction), 
thus leading to the emergence of new VTEC strains. This study investigated transduction of a verocytotoxin2-encoding 
bacteriophage (3538(vtx2::cat)) under laboratory conditions, including the effect of antibiotic treatments. Luria-Bertani 
Miller broth and rumen fluid (raw and sterilised by irradiation) were inoculated with the donor (C600φ3538(Δvtx2::cat)) 
and recipient (E. coli C600::kanamycinR) strains (4 log10 cfu/mL) and incubated at 38ºC. Antibiotic treatments (minimal 
inhibitory and sub-inhibitory concentrations of ampicillin, cefquinome, oxytetracycline and sodium sulfamethazine) 
were applied after 3 h. Samples were tested for donor, recipient, cell-free phage and transductants at times t = 0, 3, 4, 
6, 27 (24 h post-antibiotic treatment) and 51 h. Free phage was detected in the untreated broth and rumen samples, as 
were the transductants confirmed by polymerase chain reaction. The antibiotic treatments did not significantly (P > 0.01) 
increase the concentrations of free phage or transductants detected. It was therefore concluded that, under laboratory 
conditions, the antibiotics tested did not induce bacteriophage lysis, release and infection of new bacterial cells beyond 
that constitutively found in the phage population.
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Introduction
Escherichia coli are part of the normal intestinal microflora, 
although some strains cause diarrhoegenic infections in 
humans. Enteric E. coli have traditionally been divided 
into six pathotypes: enteropathogenic E. coli (EPEC), 
enterotoxigenic E. coli (ETEC), enteroinvasive E. coli (EIEC), 
verocytotoxigenic E. coli (VTEC), enteroaggregative E. coli 
(EAEC) and diffusely adherent E. coli (DAEC) (European 
Food Safety Authority [EFSA], 2013). Two further pathotypes 
have been proposed by Clements et al. (2012), including 
adherent invasive E. coli (AIEC), thought to be associated 
with Crohn’s disease, and the verocytotoxin (Vtx)-producing 
enteroaggregative E. coli (STEAEC) responsible for the 2011 
Germany E. coli outbreak.
Verocytotoxigenic E. coli (VTEC), also referred to as Shiga 
toxin-producing E. coli (STEC), are characterised by the 
production of Vtxs. These toxins, encoded on bacteriophages, 
are similar to the toxins produced by Shigella dysenteriae. 
The illnesses associated with VTEC infection range from mild-
to-bloody diarrhoea (haemorrhagic colitis) to kidney failure 
(haemolytic uremic syndrome [HUS]) and thrombocytopenia 
(Grande et al., 2014; Rahal et al., 2015).
†Corresponding author: Declan Bolton
E-mail: declan.bolton@teagasc.ie
The most common VTEC serotype associated with human illness 
worldwide has been E. coli O157:H7. This finding may reflect the 
fact that the majority of infections are caused by this serotype 
or may be the result of surveillance bias with methods and 
laboratories focussed on O157:H7. However, in recent years, 
non-O157 cases have increased and currently outnumber O157 
infections in many countries (Monaghan et al., 2012). Indeed, 
the emergence of these new VTEC serogroups has been a 
cause for serious concern. In 2011, for instance, a major VTEC 
outbreak occurred, primarily in France and Germany, but also 
affecting 12 other European Union (EU) countries, the USA and 
Canada. As on 21 July 2011, there had been 4,321 confirmed 
cases, of which 852 developed HUS and 54 died (Buchholz et 
al., 2011; Karch et al., 2012). The outbreak was unusual as the 
VTEC strain involved was an EAEC that had acquired a vtx2 
gene (Frank et al., 2011).
E. coli acquire the vtx genes by phage mediated transduction. 
When infected by the vtx-carrying lambdoid bacteriophage, 
the phage DNA integrates as a prophage into the bacterial 
chromosome, where it is replicated and transmitted to daughter 
cells during each subsequent cell division (James et al., 2001; 
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antibiotic resistance was used to detect φ3538(Dvtx2::cat) 
plaque formation in the plaque assay procedures. All bacterial 
cultures were prepared from cryoprotectant beads stored at 
–20°C and inoculated overnight at 37°C in LB broth (Sigma-
Aldrich, Wicklow, Ireland).
Antimicrobial selection and concentration
Commonly prescribed antimicrobials in bovine medicine in 
Ireland and the wider EU were selected. Each antibiotic was 
used in the broth and rumen fluid model system at SICs and 
MICs determined in a preliminary study that demonstrated 
similar values for the donor (C600φ3538(Dvtx2::cat)) 
and recipient (C600::kanamycinR) strains. The antibiotics 
used inhibited bacterial cell wall or DNA/RNA synthesis, 
potentially resulting in the bacterial SOS response. The 
final concentration of the antibiotics used were as follows: 
sodium sulfamethazine at 100 µg/mL (MIC) and 0.331 µg/mL 
(SIC); ampicillin at 50 µg/mL (MIC) and 0.011 µg/mL (SIC); 
cefquinome at 2.5 µg/mL (MIC) and 0.0011 µg/mL (SIC); and 
oxytetracycline at 25 µg/mL (MIC) and 0.0198 µg/mL (SIC). All 
antibiotics were obtained from Sigma-Aldrich.
Rumen fluid collection and preparation
One litre of rumen fluid was collected from a ruminally 
fistulated Friesian cow fed on a grass/grass silage diet on 
three separate occasions in Teagasc, Moorepark, Co. Cork, 
Ireland. The rumen fluid was collected by hand and strained 
through three layers of cheesecloth into a sterile collection 
bottle placed on ice. Approximately 500 mL of the rumen fluid 
was left untreated (raw rumen fluid), while 500 mL rumen fluid 
was irradiated (irradiated rumen fluid) at an ionizing radiation 
dose of 10 kGy at the Agri-Food and Biosciences Institute in 
Belfast, Northern Ireland. The irradiated rumen fluid provided a 
sterile environment by eliminating any background microflora 
without altering the matrix. Prior to bacterial inoculation, the 
raw and irradiated rumen fluids were tested for the presence 
of any background bacteriophages capable of infecting the 
recipient strain C600, using the method described previously 
by Nyambe et al. (2016). The raw and irradiated rumen fluids 
were stored at –20°C until required.
Broth and rumen fluid model systems
The broth and rumen fluid model systems were set up 
according to the Tilley and Terry model (Tilley and Terry, 1963). 
The broth model system consisted of 50 mL of LB broth placed 
into 100 mL (20 cm × 3 cm) glass test tubes. The rumen fluid 
system consisted of 10 mL of raw or irradiated rumen fluid 
and 40 mL of rumen buffer (26 mM Na2HPO4∙12H2O, 117 mM 
NaHCO3, 8 mM NaCl, 7.65 mM KCl, 0.63 mM MgCl2·6H2O 
and 0.54 mM CaCl2·6H2O) placed into 100 mL glass test tubes 
(Rivas et al., 2010). All test tube samples were flashed with 
CO2 for 2 min and immediately sealed with a rubber stopper 
Aertsen et al., 2005). However, these temperate phages may 
also replicate lytically. At any given time, a small percentage 
of the bacteriophage population will be in the lytic phase 
(Livny and Friedman, 2004; Iversen et al., 2015). However, 
in unfavourable conditions (e.g. antimicrobial treatments), a 
bacterial regulatory genetic repair mechanism is triggered 
(also referred to as the SOS response), which is located in a 
part of the genome that contains the phage genes encoding 
the lytic phase (Kimmitt et al., 2000; Janion, 2001; Schmidt, 
2001). Once activated, hundreds of bacteriophages are 
produced, which are then released into the environment 
when the bacterial cell lyses (Kohler et al., 2000; Colon et 
al., 2016). These phage particles are then free to infect other 
E. coli, resulting in the transfer of the vtx genes and the 
emergence of new VTEC strains (Cornick et al., 2006).
Thus, antibiotics that target DNA and/or RNA, such as 
sodium sulfamethazine (a nucleic acid inhibitor), initiate the 
lytic cycle (Kohler et al., 2000). This antibiotic is commonly 
used to treat bovine animals for bacterial pneumonia and 
bovine respiratory disease complex caused by Pasteurella 
spp., colibacillosis (bacterial scours) caused by E. coli, 
acute mastitis (Streptococcus spp.) and acute metritis 
(Streptococcus spp.), necrotic pododermatitis (foot 
rot) (Fusobacterium necrophorum) and calf diphtheria 
(Fusobacterium necrophorum). However, other antibiotics, 
including ampicillin and cefquinome (both of which disrupt 
cell wall synthesis) and oxytetracycline (which inhibits 
protein synthesis), are also widely used to treat a range of 
bovine illnesses but their impact on prophage and horizontal 
gene transfer by transduction is unknown (Morrison, 1996; 
Anderson and Yu, 2005; Kim et al., 2016). The objectives 
of this study were therefore to investigate the release of cell 
free phage and transduction in the following: (1) Luria-Bertani 
Miller (LB) broth and rumen fluid; (2) LB broth and rumen 
fluid when sodium sulfamethazine was added at sub- and 
minimum inhibitory concentrations (SIC and MIC) and (3) LB 
broth and rumen fluid treated with ampicillin, cefquinome and 
oxytetracycline (SIC and MIC).
Materials and methods
Bacterial strains
The E. coli K-12 strain C600 containing the recombinant vtx2-
encoding lysogenic bacteriophage with a chloramphenicol 
resistance marker inserted (C600φ3538(Dvtx2::cat)) was 
used as the donor strain and it was kindly provided by Dr. 
Herbert Schmidt (Hohenheim University, Germany), while 
the E. coli K-12 strain C600 with kanamycin resistance 
was used as the recipient strain (C600::kanamycinR) and 
was kindly provided by Dr. Maite Muniesa (University of 
Barcelona, Spain). The E. coli K-12 strain C600 without any 
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0.1 M CaCl2. This mixture was incubated at 37°C for 30 min, 
after which 3 mL of LB-modified top 0.7% agar (modified 
by the addition of a final concentration of 10 mM CaCl2 and 
0.001% thiamine hydrochloride) was poured onto LB-modified 
bottom agar (Sigma-Aldrich). The plates were incubated 
at 37°C overnight and examined for the formation of any 
3538(vtx2::cat) bacteriophage plaques.
Confirmation of vtx2 transductants
The DNA of the generated putative transductants obtained 
on LB agar plates containing both chloramphenicol and 
kanamycin was extracted using the DNeasy Blood and Tissue 
Kit (Qiagen, Manchester, UK). Any transductants containing 
the vtx2 3538(vtx2::cat) gene were confirmed by conventional 
polymerase chain reaction (PCR) using primers HSB1 (5′-CCC 
GGT ACC ATG AAG TGT ATA TTA TTT AAA TGG-3′) and HSB3 
(5′-CCC GCA TGC TCA GTC ATT ATT AAA CTG CAC-3′). The 
DNA was denatured at 94°C for 10 min (one cycle), followed by 
30 cycles of the following protocol: denaturing at 94°C for 30 s, 
annealing at 53°C for 1 min and extension at 72°C for 1 min; 
the experiment was concluded with a final extension step at 
72°C for 5 min (one cycle) (Schmidt et al., 1999).
Volatile fatty acid analysis
Volatile fatty acid (VFA) analysis of the rumen fluid samples 
was carried out in order to determine the concentration of 
metabolised nitrogen- and saccharide-based substances. 
VFA analysis was carried out according to a method described 
previously by Whelan et al. (2012). In brief, approximately 
10 mL of bovine rumen fluid (raw or irradiated rumen fluid) 
was centrifuged at 1,600 × g for 15 min. Exactly 200 µL of 
rumen fluid suspension was added to 3.8 mL distilled water 
containing 1 mL of internal standard (0.5 g of 3-methylvaleric 
acid in 1 L of 0.15 M oxalic acid) (Sigma Aldrich). The mixture 
was centrifuged at 1,600 × g for 5 min at 16°C and filtered using 
0.45-µm-sized membrane filters (Sartorius Stedim Ireland 
Ltd., Dublin, Ireland). The resulting filtered supernatant was 
transferred into 2 mL labelled gas chromatograph vials. VFA 
concentrations were analysed using a gas chromatograph 
(Varian 3800 GCL; Varian Inc., Palo Alto, CA, USA) fitted 
with a 15 m capillary column and coated with 1.20 µm of 
acid-modified polyethylene glycol (Grace Davison Discovery 
Sciences, Lancashire, UK).
Statistical analysis
Each experiment was performed in duplicate on three 
separate occasions, and the mean values were calculated. 
Data analysis was carried out using analysis of variance (to 
compare LB broth versus raw rumen fluid versus irradiated 
rumen fluid and the different antimicrobials) using Genstat 
version 14.1 (VSN International Ltd., Hemel Hempstead, UK). 
Significance was determined at P < 0.05.
fitted with a water-filled gas release valve. Duplicate LB broth, 
raw rumen fluid and irradiated rumen fluid model systems for 
every antibiotic treatment and concentration (SIC or MIC) were 
set up and incubated at 38°C in a water bath for 1 h before 
inoculation. In addition, LB broth, raw rumen fluid and irradiated 
rumen fluid model systems without any antibiotic treatment 
were also set up. After 1 h of incubation, all test tube samples 
were co-inoculated with 3 mL of C600φ3538(Dvtx2::cat) (donor 
strain) and 3 mL of C600::kanamycinR (recipient strain) at a 
concentration of approximately 4 log10 cfu/mL. The samples 
were flashed with CO2 and re-fitted with the rubber stoppers 
as before (Toomey et al., 2009). All test tubes were incubated 
at 38°C in a water bath without shaking.
Broth and rumen fluid sample analysis
Exactly 1 mL aliquots were taken from each of the untreated 
and treated LB broth, raw rumen fluid and irradiated rumen 
fluid test tubes at t = 0 (time of donor and recipient strain 
co-inoculation), 3 (time of antibiotic addition at SIC or MIC 
values), 4, 6, 27 (24 h after antibiotic addition) and 51 h (48 h 
after antibiotic addition). At each time point, 1 mL of the sample 
was serially diluted in 9 mL of maximum recovery diluent 
(Sigma-Aldrich) and spread-plated in duplicate. Total viable 
count (TVC) and total Enterobacteriaceae count (TEC) were 
enumerated only for the untreated and treated raw rumen 
fluid samples. TVC was enumerated by plating the samples 
on plate count agar (Sigma-Aldrich) and incubated for 48 h at 
30°C, while TEC was enumerated by plating the samples on 
violet red bile glucose agar (Sigma-Aldrich) and incubated for 
24 h at 37°C.
The formation of any putative transductants was analysed by 
plating on LB agar containing both 30 µg/mL chloramphenicol 
and 50 µl/mL kanamycin and incubated at 37°C overnight. 
During the course of the incubation and antibiotic treatment 
period, the survival of donor strains (C600φ3538(Dvtx2::cat)) 
was analysed by plating the samples on LB agar containing 
30 µg/mL chloramphenicol and that of recipient strains 
(C600::kanamycinR) by plating on LB agar containing 
50 µl/mL kanamycin and incubating both at 37°C overnight.
Detection of free vtx2 bacteriophage in broth and rumen 
fluid
To detect the presence of free phage in the untreated and 
treated LB broth and rumen fluid (raw or irradiated), 2 mL 
aliquots were extracted at each time point. Each extracted 
aliquot was centrifuged at 6,797 × g for 10 min and filtered 
using 0.45- µm-sized membrane filters (Sartorius Stedim Ltd., 
Dublin, Ireland). A serial dilution of the free vtx2 bacteriophage 
suspension was carried out using LB broth supplemented 
with a final concentration of 10 mM CaCl2. Exactly 100 µL 
of the diluted, filtered bacteriophage suspension was added 
to 100 µL of overnight C600 host cell culture and 125 µL of 
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obtained in the different matrices: LB broth (2.8 log10 pfu/mL) 
after 27 h with sodium sulfamethazine (MIC); raw rumen fluid 
(3.9 log10 pfu/mL) after 4 h with oxytetracycline (SIC); and 
irradiated rumen fluid (2.7 log10 pfu/mL) after 27 h in untreated 
samples.
Despite the apparent abundance of cell-free phages 
obtained in untreated and treated samples, PCR-confirmed 
transductants were only detected in 18 samples, and the 
concentrations were low at 0.1–0.8 log10 cfu/mL (Tables 2 
and 3). Interestingly, eight positives were obtained in sodium 
sulfamethazine-treated samples, two with ampicillin, three 
with cefquinome, three with oxytetracycline and the remainder 
in untreated samples. The majority were obtained in LB broth 
(15), with one in raw rumen fluid and three in irradiated rumen 
fluid.
Discussion
Although it has been suggested that antimicrobials may trigger 
the proliferation of new phage via the lytic cycle, there is a 
lack of research demonstrating this process and the potential 
emergence of new VTEC strains (Kimmitt et al., 2000; Free et 
al., 2012; Kim et al., 2016). Induction, the process by which 
phages switch from the lysogenic cycle to the lytic cycle, is 
triggered by the SOS response in bacteria, which in turn is 
induced by activation of the RecA protein after binding to 
single-stranded DNA fragments, which are the products of 
damaged DNA (Walker, 1984; Sassanfar and Roberts, 1990). 
DNA damage may be caused by UV radiation, chemicals 
such as hydrogen peroxide or antibiotics or infection with 
other phages (Campbell and Reece, 2005; Campoy et 
al., 2006; Keen, 2012). In our study, cell-free phages, at 
concentrations ranging from 0.4 to 2.7 log10 pfu/mL, were 
detected in untreated LB broth, raw rumen fluid and irradiated 
rumen fluid at both SIC and MIC throughout this experiment, 
suggesting that within a VTEC population, a proportion of the 
Results
The raw rumen fluid, which had acetic, propionic, iso-butyric, 
butyric, iso-valeric and valeric acid concentrations of 82.6, 
15.7, 2.5, 18.8, 2.9 and 2.4 mmol/L, respectively, tested 
negative for bacteriophages capable of infecting the host 
strain (C600) used in these studies. Raw rumen fluid TVC and 
TEC values ranged from 5.1 to 5.9 log10 cfu/mL and were not 
affected by sodium sulfamethazine, ampicillin, cefquinome 
or oxytetracycline, regardless of the concentration applied 
(SIC or MIC) as their populations increased by approximately 
1.0–1.5 log10 cfu/mL after treatment (Table 1). In contrast, 
their effect on the donor and recipient E. coli populations was 
mixed, depending on the antibiotic, concentration used and 
the matrix (Tables 2 and 3). At SIC values, a 1–2 log10 cfu/mL 
decrease in donor E. coli populations was obtained in the raw 
and irradiated rumen fluids when treated with all antibiotics, 
while recipient concentrations remained relatively stable when 
antibiotic treatments were applied in LB broth, raw rumen 
fluid and irradiated rumen fluid. At MIC values in LB broth, 
both the donor and the recipient E. coli C600 populations 
decreased by up to 5 log10 cfu/mL after ampicillin, cefquinome 
and oxytetracycline treatments, but sulfamethazine had no 
effect. A similar pattern was observed in raw rumen fluid and 
irradiated rumen fluid, although the reductions obtained were 
generally lower (up to approximately 2 log10 cfu/mL), and 
sulfamethazine reduced the donor but not the recipient E. coli 
populations (Tables 2 and 3).
Interestingly, cell-free phages were detected in untreated 
samples of all three matrices at concentrations of up to 2.7 
log10 plaque-forming units (pfu)/mL (Tables 2 and 3). There 
were statistically significant (P < 0.05) differences in the cell-
free phage concentrations obtained with the different antibiotic 
treatments depending on the sampling time (0, 3, 4, 6, 27 or 
51 h); thus there was no clear pattern wherein one antibiotic 
consistently achieved significantly (P < 0.05) higher cell-free 
phage concentrations. A range of peak concentrations were 
Table 1. Total viable counts and total Enterobacteriaceae counts in untreated and treated raw rumen fluids
Time 
(h)
TVC, log10 cfu/mL 
(antibiotics at SIC)
TEC, log10 cfu/mL 
(antibiotics at SIC)
TVC, log10 cfu/mL
 (antibiotics at MIC)
TEC, log10 cfu/mL 
(antibiotics at MIC)
NT Amp Cef Sul Oxy NT Amp Cef Sul Oxy NT Amp Cef Sul Oxy NT Amp Cef Sul Oxy
0 5.8 5.8 5.9 5.6 5.9 5.1 5.5 5.1 5.7 5.8 5.8 5.5 5.2 5.7 5.6 5.1 5.1 5.5 5.1 5.1
3 6.6 6.7 6.6 6.6 7.3 6.0 5.9 5.7 6.3 7.0 6.6 6.8 6.2 6.5 6.9 6.0 6.7 5.9 6.6 5.8
4 6.9 6.9 6.9 6.8 6.7 6.7 6.5 5.8 5.9 6.1 6.9 6.9 6.5 6.2 6.7 6.7 5.6 5.7 4.9 5.9
6 6.8 6.2 6.6 6.5 5.9 6.5 5.7 5.6 6.6 5.9 6.8 6.1 6.5 6.5 6.6 6.5 5.5 5.5 5.9 5.6
27 7.2 6.5 6.5 6.6 6.2 6.7 6.6 6.5 6.5 6.7 7.2 6.1 6.2 6.2 6.5 6.7 6.5 5.8 6.5 6.6
51 6.8 6.6 6.2 6.2 6.6 6.4  6.3 6.2 6.1  6.0 6.8 5.8 6.1 5.9 5.6 6.4 6.3 5.5 6.0 5.0
Amp = ampicillin; Cef = cefquinome; MIC = minimal inhibitory concentration; NT = no treatment; Oxy = oxytetracycline; SIC = sub-inhibitory 
concentrations; Sul = sodium sulfamethazine; TEC = total Enterobacteriaceae count; TVC = total viable count.
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Table 2. Donor (C600φ3538(Dvtx2::cat)), recipient (E. coli C600::kanamycinR), cell-free phages and PCR-confirmed transductants obtained 
in untreated and treated (ampicillin: 0.011 µg/mL; cefquinome: 0.0011 µg/mL; sodium sulfamethazine: 0.331 µg/mL; and oxytetracycline: 
0.0198 µg/mL) LB broth, raw rumen fluid and irradiated rumen fluid at SIC
Time
(h)
Donor: E. coli 
C600φ3538(Dvtx2::cat), 
log10 cfu/mL
Recipient: E. coli 
C600::kanamycinR, 
log10 cfu/mL
Cell-free phage, 
log10 pfu/mL
PCR-confirmed transductants, 
log10 cfu/mL
NT Sul Amp Cef Oxy NT Sul Amp Cef Oxy NT Sul Amp Cef Oxy NT Sul Amp Cef Oxy 
LB broth
0 4.9a 4.8a 5.0a 4.9a 4.4a 4.6a 4.9a 5.2a 4.4a 5.0a 0.0a 0.0a 0.0a 0.0a 0.0a ND ND ND ND ND
3 5.2a 5.1a 5.3a 5.1a 5.8a 5.9a 5.5a 5.4a 5.6a 5.9a 0.4a 0.9a 0.4a 0.5a 0.5a ND 0.1 ND ND 0.1
4 6.3a 6.0a 4.5a 5.1a 4.9a 6.3a 6.2a 5.2a 5.6a 5.3a 1.1a 1.7a 0.6b 2.0a 2.2a 0.5 0.5 0.4 0.3 ND
6 6.3a 5.0a 4.3a 5.2a 4.7a 6.7a 5.5a 5.3a 5.6a 4.9a 2.1a 0.5b 1.8a 1.8a 1.7a ND 0.8 ND 0.2 ND
27 5.9a 4.6a 4.5a 4.6a 5.4a 6.5a 5.3a 4.9a 5.6a 5.3a 1.0a 0.8b 0.7b 0.7b 1.8a ND ND ND ND ND
51 4.0a 4.1a 3.1b 4.6a 4.7a 5.4a 4.3a 5.4a 5.6a 4.9a 0.8b 0.4b 1.4a 0.4b 0.5b ND 0.5 0.3 ND 0.5
Raw rumen fluid
0 4.3a 4.1a 4.4a 4.5a 3.9a 4.9a 4.6a 4.6a 4.8a 4.6a 0.0a 0.0a 0.0a 0.0a 0.0a ND ND ND ND ND
3 4.5a 4.5a 4.5a 4.2a 4.3a 4.8a 4.9a 5.5a 4.9a 5.0a 0.5b 0.5b 0.5b 1.1a 1.2a ND ND ND ND ND
4 4.4a 4.0a 4.1a 4.1a 3.9a 5.3a 4.7a 4.9a 5.0a 4.8a 0.6b 2.1a 2.5a 2.7a 3.9a ND ND ND ND ND
6 3.6b 3.6b 3.7b 3.6b 3.5b 5.3a 4.6a 4.9a 4.9a 4.5a 2.4a 1.4b 0.7b 1.3b 2.1a ND ND ND ND ND
27 4.2a 3.7a 3.3b 4.4a 3.9a 6.0a 4.6a 5.0a 4.4a 4.7a 1.4b 1.0b 2.0a 1.1b 0.7b 0.8 ND ND ND ND
51 3.8a 4.0a 2.2b 3.0a 2.2b 5.6a 4.4a 5.0a 4.5a 5.0a 0.7b 1.8a 0.7b 1.3a 0.6b ND ND ND ND ND
Irradiated rumen fluid
0 4.4a 4.5a 4.5a 4.6a 4.7a 4.8a 4.8a 5.0a 4.9a 5.3a 0.0a 0.0a 0.0a 0.0a 0.0a ND ND ND ND ND
3 4.8a 4.7a 4.7a 4.6a 4.8a 5.6a 5.5a 5.5a 5.4a 5.2a 0.5a 0.4b 0.4b 1.0a 0.5a ND ND ND ND ND
4 4.9a 4.6a 4.6a 5.1a 4.5a 6.3a 5.5a 4.8a 4.9a 5.6a 2.7a 0.5b 1.6a 1.0b 0.5b ND ND ND ND ND
6 4.8a 3.7b 3.6b 3.8b 3.5b 6.1a 4.3a 4.9a 4.9a 4.7a 2.7a 1.5a 1.3b 1.4b 1.4b 0.1 ND ND ND ND
27 4.9a 3.4b 3.4b 2.9b 2.3c 5.3a 4.9a 5.0a 4.3a 4.6a 1.7a 1.3b 1.2b 0.8b 2.6a 0.2 ND ND ND ND
51 3.5a 2.5b 2.4b 1.6b 2.1 5.3a 4.9a 4.3a 4.6a 4.9a 0.7b 2.0a 1.4b 0.7b 1.5a ND ND ND 0.6 ND
a-cStatistical analysis: the same letter indicates statistically similar results (P < 0.05) horizontally within a given group (donor, recipient or cell-
free phage).
Amp = ampicillin; Cef = cefquinome; LB = Luria-Bertani Miller; NT = no treatment; ND = not detected; Oxy = oxytetracycline; PCR = polymerase 
chain reaction; SIC = sub-inhibitory concentrations; Sul = sodium sulfamethazine; TEC = total Enterobacteriaceae count; TVC = total viable 
count.
phages are constitutively replicating at any given time via the 
lytic cycle. This finding has been previously reported (Livny 
and Friedman, 2004; Iversen et al., 2015). Such a mechanism 
would ensure phage persistence even if bacterial inactivation 
processes were rapid and the VTEC hosts did not survive 
for sufficient time to allow phage release before being killed 
(Martinez-Castillo and Muniesa, 2014).
Interestingly, cell-free phage populations peaked after 4–6 h 
in SIC-treated samples, at 2.0–2.6 log10 pfu/mL, regardless 
of the medium. Similar peak cell-free phage concentrations 
were obtained at the MIC values (2.1 log10 log10 pfu/mL in 
LB broth, 2.4 log10 pfu/mL in raw rumen fluid and 2.7 log10 
pfu/mL in irradiated rumen fluid) after the same time period. 
The decrease in free phages from their peak values was 
unexpected as viral pathogens are generally considered to 
survive better that their cellular hosts, a phenomenon that has 
been demonstrated with Vtx phages (Muniesa et al., 1999; 
Lucena et al., 2003; Skraber et al., 2004). Moreover, the 
peak phage concentrations were similar to those previously 
recorded in human, cattle and poultry waste water and in 
bovine faeces (Imamovic et al., 2010; Rooks et al., 2012). 
As these samples were taken from sources that form part of 
the natural ecology of E. coli, it is unlikely the E. coli cells 
were in an SOS-stressed state, providing further evidence for 
constitutive replication via the lytic cycle within a Vtx phage 
population.
Despite cell-free phage being obtained in all three matrices at 
concentrations of up to 3.9 log10 log10 pfu/mL, transductants 
were only detected in 20 samples and even then, at low 
concentrations (0.1–0.8 log10 cfu/mL). A majority of these 
occurred in LB broth, especially when treated with sodium 
sulfamethazine. This may reflect the fact that antibiotics that 
target DNA more effectively induce the lytic phase, even at 
low concentrations (SIC and MIC) (Kohler et al., 2000), but 
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Vtx phages replicate via the lytic cycle in broth and rumen 
fluid model systems even in the absence of the bacterial 
SOS response; (2) sodium sulfamethazine at SIC and MIC 
promotes this process; and (3) in contrast, other antibiotics, 
specifically ampicillin, cefquinome and oxytetracycline (at SIC 
and MIC), have no effect.
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this may also be due to the higher concentration of donor 
and recipient cells in sodium sulfamethazine-treated samples 
(Imamovic et al., 2009). Indeed, the low overall production 
and isolation of transductants may be attributed to the 
combination of donor and recipient cell concentrations being 
lower than the threshold value required for their generation, 
due to the decrease in bacterial cell numbers observed in 
the presence of the different antibiotic treatments (Imamovic 
et al., 2009). Moreover, the free phages observed in our 
study may have had reduced capacity to infect bacterial cells 
(Yue et al., 2012; Martinez-Castillo and Muniesa, 2014). The 
higher transduction rates in LB broth may be explained by 
the impact of the matrix on this process. In general, more 
complex and heterogeneous matrices, such as rumen 
fluid, inhibit transduction as the irregular distribution of cells 
reduces phage–bacteria encounters (Imamovic et al., 2009).
Based on our findings, the following conclusions were drawn: 
(1) within a given VTEC population, a proportion of the 
Table 3. Donor (C600φ3538(Dvtx2::cat)), recipient (E. Coli C600::kanamycin
R), cell-free phages and PCR-confirmed transductants obtained 
in untreated and treated (ampicillin: 50 µg/mL; cefquinome: 2.5 µg/mL; sodium sulfamethazine: 100 µg/mL; and oxytetracycline: 25 µg/mL) 
LB broth, raw rumen fluid and irradiated rumen fluid at MIC
Time 
(h)
Donor: E. coli 
C600φ3538(Dvtx2::cat), log10 cfu/mL
Recipient: E. coli 
C600::kanamycinR, log10 cfu/mL
Cell-free phage, log10 pfu/mL PCR-confirmed transductants, 
log10 cfu/mL
NT Sul Amp Cef Oxy NT Sul Amp Cef Oxy NT Sul Amp Cef Oxy NT Sul Amp Cef Oxy
LB broth
0 4.9a 4.4a 4.9a 4.9a 4.6a 4.6a 4.9a 4.8a 5.0a 4.7a 0.0a 0.0a 0.0a 0.0a 0.0a ND ND ND ND ND
3 5.2a 5.5a 5.0a 5.1a 4.6a 5.9a 5.9a 5.2a 5.6a 5.0a 0.4a 1.0a 0.5a 0.5a 0.4a ND ND ND ND ND
4 6.3a 5.6a 2.8b 3.4b 3.6b 6.3a 6.3a 3.0b 4.0b 3.8b 1.1a 0.6a 0.5a 2.3b 2.1b 0.5 0.6 ND ND ND
6 6.3a 5.4a 1.3b 1.4b 1.8b 6.7a 5.2a 2.1b 1.9b 2.5b 2.1a 1.8a 2.1a 1.7a 2.7a ND 0.6 ND ND ND
27 5.9a 5.3a 0.0b 0.7b 1.1b 6.5a 5.3a 0.4b 1.0b 1.9b 1.0a 2.8b 0.6a 1.6a 0.7a ND 0.7 ND ND ND
51 4.0a 4.5a 0.0b 0.0b 1.2b 5.4a 4.6a 0.0b 0.0b 1.5b 0.8a 0.7a 0.0a 0.0a 1.1a ND 0.7 ND ND 0.5 
Raw rumen fluid
0 4.3a 4.2a 4.1a 4.4a 3.8a 4.9a 4.9a 4.2a 4.8a 4.5a 0.0a 0.0a 0.0a 0.0a 0.0a ND ND ND ND ND
3 4.5a 4.2a 5.1a 4.7a 4.2a 4.8a 4.9a 5.1a 5.2a 5.1a 0.5b 1.2b 1.0b 2.0a 1.2b ND ND ND ND ND
4 4.4a 3.7a 4.2a 3.7a 4.4a 5.3a 4.9a 4.8a 4.8a 4.7a 0.6b 1.2b 2.7a 3.0a 1.3b ND ND ND ND ND
6 3.6a 3.6a 2.8a 2.8a 3.7a 5.3a 4.6b 4.2b 4.7b 4.2b 2.4a 2.1a 1.4b 1.8b 1.4b ND ND ND ND ND
27 4.2a 4.1a 2.5b 2.2b 4.2a 6.0a 5.1b 4.4b 4.0b 4.3b 1.4b 2.0a 1.0b 1.4b 1.5b 0.8 ND ND ND ND
51 3.8a 2.3b 2.5b 0.7c 3.2a 5.6a 4.3a 3.9a 3.6a 4.7a 0.7b 1.8a 1.5a 1.4a 0.8b ND ND ND ND ND
Irradiated rumen fluid
0 4.4a 4.7a 4.2a 4.5a 4.8a 4.8a 4.3a 4.8a 4.6a 4.9a 0.0a 0.0a 0.0a 0.0a 0.0a ND ND ND ND ND
3 4.8a 4.7a 4.8a 5.0a 4.9a 5.6a 5.2a 5.3a 5.3a 5.5a 0.5b 1.0a 1.3a 1.1a 1.0a ND ND ND ND ND
4 4.9a 4.9a 3.9a 3.6a 4.1a 6.3a 5.6b 4.7b 4.9b 4.9b 2.7a 1.0b 1.2b 1.2b 1.2b ND ND ND ND ND
6 4.8a 4.0a 2.2b 2.9b 3.2b 6.1a 4.6b 3.5b 3.5b 4.0b 2.7a 2.0a 1.3b 1.4b 1.4b 0.1 ND ND ND ND
27 4.9a 3.1b 1.2c 1.5c 3.5b 5.3a 4.7a 2.5b 3.5b 3.1b 1.7a 2.0a 2.0a 1.6a 2.0a 0.2 ND ND ND ND
51 3.5a 2.9a 0.0c 0.7c 2.1b 5.3a 5.0a 2.1c 3.3b 3.6b 0.7b 1.8a 1.3a 1.4a 1.4a ND ND ND ND ND
a-cStatistical analysis: the same letter indicates statistically similar results (P < 0.05) horizontally within a given group (donor, recipient or cell-
free phage).
Amp = ampicillin; Cef = cefquinome; LB = Luria-Bertani Miller; MIC = minimal inhibitory concentration; NT = no treatment; ND = not detected; 
Oxy = oxytetracycline; PCR = polymerase chain reaction; Sul = sodium sulfamethazine; TEC = total Enterobacteriaceae count; TVC = total 
viable count.
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